Cargando…

Tyrosine Kinase Inhibitors Target B Lymphocytes

Autoimmune disorders and some types of blood cancer originate when B lymphocytes malfunction. In particular, when B cells produce antibodies recognizing the body’s proteins, it leads to various autoimmune disorders. Additionally, when B cells of various developmental stages transform into cancer cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Upfold, Nikki Lyn Esnardo, Petakh, Pavlo, Kamyshnyi, Aleksandr, Oksenych, Valentyn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046234/ https://www.ncbi.nlm.nih.gov/pubmed/36979373 http://dx.doi.org/10.3390/biom13030438

Ejemplares similares

The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin
por: Petakh, Pavlo, et al.
Publicado: (2023)

Interaction between Fibroblasts and Immune Cells Following DNA Damage Induced by Ionizing Radiation
por: Ragunathan, Kalaiyarasi, et al.
Publicado: (2020)

Weil’s Disease—Immunopathogenesis, Multiple Organ Failure, and Potential Role of Gut Microbiota
por: Petakh, Pavlo, et al.
Publicado: (2022)

Metformin Therapy Changes Gut Microbiota Alpha-Diversity in COVID-19 Patients with Type 2 Diabetes: The Role of SARS-CoV-2 Variants and Antibiotic Treatment
por: Petakh, Pavlo, et al.
Publicado: (2023)

Immunoregulatory Intestinal Microbiota and COVID-19 in Patients with Type Two Diabetes: A Double-Edged Sword
por: Petakh, Pavlo, et al.
Publicado: (2022)

Risks of outbreaks: The health concerns of internally displaced persons in Transcarpathia, Ukraine
por: Petakh, Pavlo, et al.
Publicado: (2023)

Gut microbiota in patients with COVID-19 and type 2 diabetes: A culture-based method
por: Petakh, Pavlo, et al.
Publicado: (2023)

Effects of metformin on the gut microbiota: A systematic review
por: Pavlo Petakh, et al.
Publicado: (2023)

Unveiling the potential pleiotropic effects of metformin in treating COVID-19: a comprehensive review
por: Petakh, Pavlo, et al.
Publicado: (2023)

Almond Consumption and Inflammatory Biomarkers: A Need for Further Investigation
por: Petakh, Pavlo, et al.
Publicado: (2023)

Infectious diseases during the Russian-Ukrainian war - Morbidity in the Transcarpathian region as a marker of epidemic danger on the EU border
por: Petakh, Pavlo, et al.
Publicado: (2023)

Association of Myocardial Changes and Gene Expression of the NFATC1 and NFATC4—Calcineurin Signaling Pathway in Children with Bicuspid Aortic Valve
por: Kamenshchyk, Andrii, et al.
Publicado: (2023)

The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence
por: Buchynskyi, Mykhailo, et al.
Publicado: (2023)

Altered Blood Molecular Markers of Cardiovascular Function in Rats after Intrauterine Hypoxia and Drug Therapy
por: Popazova, Olena, et al.
Publicado: (2023)

Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis
por: Buchynskyi, Mykhailo, et al.
Publicado: (2023)

Cardioprotective Activity of Pharmacological Agents Affecting NO Production and Bioavailability in the Early Postnatal Period after Intrauterine Hypoxia in Rats
por: Popazova, Olena, et al.
Publicado: (2023)

Efficacy of interferon alpha for the treatment of hospitalized patients with COVID-19: A meta-analysis
por: Buchynskyi, Mykhailo, et al.
Publicado: (2023)

Acetyltransferases GCN5 and PCAF Are Required for B Lymphocyte Maturation in Mice
por: Oksenych, Valentyn, et al.
Publicado: (2021)

Therapeutic Effectiveness of Interferon-α2b against COVID-19 with Community-Acquired Pneumonia: The Ukrainian Experience
por: Kamyshnyi, Aleksandr, et al.
Publicado: (2023)

Oral Administration of Myelin Oligodendrocyte Glycoprotein Attenuates Experimental Autoimmune Encephalomyelitis through Induction of Th2/Treg Cells and Suppression of Th1/Th17 Immune Responses
por: Haghmorad, Dariush, et al.
Publicado: (2022)

Case report: Azithromycin-meropenem combination therapy as a low-cost approach to combat PDR gram-negative infections of war wounds in Ukraine
por: Kryzhevskyi, Vadym, et al.
Publicado: (2023)

Editorial: Plasticity of immune cells in tumor microenvironment
por: Oksenych, Valentyn
Publicado: (2023)

DNA Repair and Immune Response: Editorial
por: Oksenych, Valentyn
Publicado: (2022)

The evolving role of Bruton’s tyrosine kinase inhibitors in chronic lymphocytic leukemia
por: Gordon, Max J., et al.
Publicado: (2021)

Targeting tumour microenvironment by tyrosine kinase inhibitor
por: Tan, Hor-Yue, et al.
Publicado: (2018)

Gut microbiota status in leptospirosis: An unrecognized player?
por: Petakh, Pavlo, et al.
Publicado: (2022)

Genetic interaction between DNA repair factors PAXX, XLF, XRCC4 and DNA‐PKcs in human cells
por: Xing, Mengtan, et al.
Publicado: (2019)

Involvement of Fyn tyrosine kinase in progression of cytokinesis of B lymphocyte progenitor
Publicado: (1996)

Non-Covalent Bruton’s Tyrosine Kinase Inhibitors in the Treatment of Chronic Lymphocytic Leukemia
por: Montoya, Skye, et al.
Publicado: (2023)

Broad-Spectrum Antivirals and Antiviral Combinations: An Editorial Update
por: Kainov, Denis, et al.
Publicado: (2022)

Non-Homologous End Joining Factors XLF, PAXX and DNA-PKcs Maintain the Neural Stem and Progenitor Cell Population
por: Gago-Fuentes, Raquel, et al.
Publicado: (2020)

Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML
por: Allert, Catana, et al.
Publicado: (2022)

Morphological prediction of lethal outcomes in the evaluation of lung tissue structural changes in patients on respiratory support with СOVID-19: Ukrainian experience
por: Matskevych, Viktoriya, et al.
Publicado: (2023)

Tyrosine Kinase Inhibitors and Interferon
por: Dimou, Maria, et al.
Publicado: (2014)

Tyrosine Kinase Inhibitors and Pregnancy
por: Abruzzese, Elisabetta, et al.
Publicado: (2014)

Innate T-αβ lymphocytes as new immunological components of anti-tumoral “off-target” effects of the tyrosine kinase inhibitor dasatinib
por: Barbarin, Alice, et al.
Publicado: (2020)

Activation of the Syk tyrosine kinase is insufficient for downstream signal transduction in B lymphocytes
por: Hsueh, Robert C, et al.
Publicado: (2002)

Targeting Bruton tyrosine kinase using non-covalent inhibitors in B cell malignancies
por: Gu, Danling, et al.
Publicado: (2021)

Targeted polypharmacology: Discovery of dual inhibitors of tyrosine and phosphoinositide kinases
por: Apsel, Beth, et al.
Publicado: (2008)

Novel Tyrosine Kinase Inhibitors to Target Chronic Myeloid Leukemia
por: Ciaffaglione, Valeria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8rj5igff0r6dhvpmdd08ia5sa3